Category: Do you speak LallianSe ?

Met almost 20 years ago in another life as an #investor, Karine joined the #LallianSe adventure by supporting its strategy through her commitment as a member of the strategic steering committee.

It is shared values, sincere friendship, associative commitment and professional complementarity which have been established and consolidated over time. Thank you for these wonderful years of trust.

Meet Karine Lignel, co-founder and General Director of Oncodesign Precision Medicine – OPM in our #𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

#health#DYSL #innovation #synergies #partnership #network

Our collaborations arise from a mutual desire to transform innovation and develop it in care.

Between @Hôtel-Dieu and its Apéros de l’Innovation, the #Agora of digital care, #APInnov and more recently #ASIIA (Association of Innovative Companies from AP-HP), so many initiatives which are starting a innovative dynamic, promote and support the creation of #startups, in connection with one of the largest (eco)health systems in Europe, the #APHP.

Meet Nicolas Castoldi, Deputy Director to the Director General of AP-HP, Assistance Publique – Hôpitaux de Paris,in our #𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

#health #DYSL #innovation #hospital #partnership #network

First integrated into the LallianSe #community through our #events, Carole Neves joined our #community of #Experts in residence as Sparring and Operating partner, particularly with EVerZom and international clients.

Our common ambition to support the creation and development of start-ups, combined with Carole‘s keen #expertise in rare diseases, gene therapies and other innovative products, allows us to offer a 360° vision of the challenges of business development and health products

Ultimately, it is a #synergy that supports the startup’s value creation and actively contributes to its success.

Meet Carole Neves in our #𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

 #health #DYSL #team #Expert #XIR

Since its creation in 1947, by supporting research, the Fondation pour la Recherche Médicale plays a crucial role in the development of research projects and support for researchers. 

The #valorization of this work represents a strategic and significant approach while resulting from a plural and complex process. This is why, with our know-how and our tailor-made courses, #LallianSe has been supporting the #FRM for several years to initiate, explore and develop its inspiring and original approach, making it a unique player in the valorization and maturation of biomedical research projects.

More than a #collaboration, this relationship is based on common values and a shared ambition. We are proud to count the #FRM among our #partners.

Meet Benjamin PRUVOST in our #𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

#health #DYSL #team #foundation #network #community

Recently graduated Doctor of #Pharmacy, Eilone Abensour has led important work on the question of how #CDMOs drive innovation within the biologics industry.

With her in-depth understanding of the CDMO market and landscape, as well as her experience in #capitaldev, Eilone joined our #Expert #network a few months ago as a junior project manager. At (only) 27 years old, his added value and vision brought dynamic energy and strengthened our commitment to the younger generation.

At #LallianSe, we believe in the power of #synergies, #network and shared #values.

Meet Eilone in our 𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

#health #DYSL #team

For more than 70 years, the Fondation pour la Recherche Médicale has been the essential private player in financing biomedical research in France.

Since 2013, through the management of the Béatrice Denys Foundation under the aegis of the #FRM, the relationship with Julie has been created. And, since 2019 #LallianSe has been supporting the #FRM to initiate, explore and develop its inspiring and original approach to become a relevant player in the promotion and maturation of research projects.

Beyond the #sparringpartner and #operatingpartner approach, Julie and Emmanuelle have built a relationship of trust and quality by concretizing strategic issues, supporting operational implementation, by carrying out targeted interactions with stakeholders. keys while supporting internal teams on a daily basis.

A concrete and inspiring example based on values and our common ethics. Thank you to Valerie Lemarchandel & Florence Guibal and all the FRM teams for your trust!

Meet Valerie & Florence in our 𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

#health #DYSL #team #Foundation

First requested for the communication strategy of our flagship initiative, BrainTale, it was with great enthusiasm that we were able to be challenged by Anna in the writing of our #LallianSe story.

To share our vision and our different tailor-made courses, we wanted to assert our specificity while preserving our #DNA. Anna brought a unique perspective to our team and guided us to bring our story to life in an authentic and inspiring way. His expertise was instrumental in articulating our values, our passion and our commitment in a clear and convincing manner.

At #LallianSe,we believe in the power of #synergies, #network and shared #values.

Meet Anna Casal, communications specialist in France and internationally (and much more!) in our #𝐃𝐨𝐘𝐨𝐮𝐒𝐩𝐞𝐚𝐤𝐋𝐚𝐥𝐥𝐢𝐚𝐧𝐒𝐞?

#health #innovation #communication #storytelling #DYSL

Meet Pierre-Emmanuel Gérard, President, Founder & CEO of Biomunex.

It is through a common vision oriented around the #patient and the #medical #community that our links with BIOMUNEX PHARMACEUTICALS have been built.

For almost 5 years, with an Expert-in-Residence at the helm of the outsourced Financial Department, #LallianSe has accompanied #Biomunex around different strategic and operational perspectives.

Meeting the needs of innovative companies with agility, flexibility and tailor-made: our commitment and our DNA since 2015!

Key development challenges for the company in the coming months to actively contribute through its science of excellence, its relevant positioning and its top team:

Meet Pierre-Emmanuel Gerard, President, Founder and CEO of Biomunex, in our 𝘋𝘰 𝘠𝘰𝘶 𝘚𝘱𝘦𝘢𝘬 𝘓𝘢𝘭𝘭𝘪𝘢𝘯𝘚𝘦?

#synergies #network #values #health #innovation #biotech #healthcare #immunotherapy #XIR